|
Edison Investment Research Limited
 London, UK, 10 June 2020 Edison issues flash on Ergomed (ERGO) Today Ergomed held its annual general meeting (AGM). As expected, no new financial details were provided, although the executive chairman released a statement with a general business update. Q120 trading was good with 'solid overall growth in revenue' and cash generation 'remained strong'. In Q220, Ergomed continued to grow the order book across the business and maintained its 'revenue growth trend'. Its staff successfully adapted to remote working conditions and no employees were made redundant or furloughed. The H120 trading update will be released in July 2020 as usual, but Ergomed stated within its AGM update (June 10) that it is confident the results will be 'in line with current market expectations'.  The next trading update is expected in July 2020, which is when we will review our estimates and update the valuation. Â
 to Edison's content to receive reports by email. All reports published by Edison are free-to-access and available on the .  About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the . Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities. For more information please contact Edison: Dr Jonas Peciulis, +44 (0)20 3077 5728  Learn more at and connect with Edison on: LinkedIn       Twitter          YouTube     Â
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
1067543Â Â 10-Jun-2020Â
